Japan Tobacco Inc. announced resolutions from the Board of Directors concerning the Company's new executive appointment. Newly appointed Executive Officer (Effective from July 1, 2024): Takayuki Yamaguchi as Senior Vice President, President, Pharmaceutical Business. Resigning Executive Officer (As of June 30, 2024): Muneaki Fujimoto as Senior Vice President, President, Pharmaceutical Business.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,370 JPY | -0.79% | -0.43% | +19.89% |
05-14 | Jefferies Adjusts Japan Tobacco’s Price Target to 3,741 Yen From 3,353 Yen, Keeps at Hold | MT |
05-10 | Japan Tobacco's Attributable Profit Up 9% in Q1 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.89% | 49.74B | |
+12.82% | 79.63B | |
-7.90% | 63.33B | |
-0.46% | 7.01B | |
-22.35% | 4.92B | |
-6.50% | 2.39B | |
-10.09% | 2.14B | |
-37.40% | 1.49B | |
-15.45% | 1.11B | |
-2.34% | 985M |
- Stock Market
- Equities
- 2914 Stock
- News Japan Tobacco, Inc.
- Japan Tobacco Inc. Announces Executive Changes